Impact of an Education Program for Caregivers of Patients with Alzheimer's Disease on Treatment Discontinuation and Compliance in Korea
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Reportedly 30–50% of patients being treated for chronic illnesses do not adhere to their medication regimen. We assessed the impact of a nurse-led education program for caregivers of Korean de novo Alzheimer’s disease patients who had newly been prescribed donepezil. Methods This multicenter study analyzed 93 participants in a caregiver education group and 92 participants in a caregiver no-education group. At every visit up to the end of the study (1 year), caregivers in the education group were given educational brochures regarding Alzheimer’s disease and the efficacy and adverse events of donepezil treatment. The primary endpoint was the discontinuation rate of donepezil treatment during the 1-year observation period. The secondary endpoints included the effect of education on compliance with donepezil treatment assessed at each visit using a clinician rating scale (CRS) and visual analog scale (VAS), and changes from baseline in cognitive assessment tests. Results The donepezil discontinuation rates at 1 year were 5.38% (5/93) and 6.52% (6/92) in the caregiver education and no-education groups, respectively (p=0.742). No significant between- group differences in donepezil compliance rates on the CRS and VAS were observed, but significant changes were observed in some cognitive tests from baseline to the end of the study. Conclusions Caregiver education had no significant effect on treatment discontinuation, but this may have been due to the low severity of cognitive impairment among the included population at baseline. In addition, the low discontinuation rates meant that no significant difference in treatment compliance was observed.
Abstract
Background and Purpose Reportedly 30–50% of patients being treated for chronic illnesses do not adhere to their medication regimen. We assessed the impact of a nurse-led education program for caregivers of Korean de novo Alzheimer’s disease patients who had newly been prescribed donepezil. Methods This multicenter study analyzed 93 participants in a caregiver education group and 92 participants in a caregiver no-education group. At every visit up to the end of the study (1 year), caregivers in the education group were given educational brochures regarding Alzheimer’s disease and the efficacy and adverse events of donepezil treatment. The primary endpoint was the discontinuation rate of donepezil treatment during the 1-year observation period. The secondary endpoints included the effect of education on compliance with donepezil treatment assessed at each visit using a clinician rating scale (CRS) and visual analog scale (VAS), and changes from baseline in cognitive assessment tests. Results The donepezil discontinuation rates at 1 year were 5.38% (5/93) and 6.52% (6/92) in the caregiver education and no-education groups, respectively (p=0.742). No significant between- group differences in donepezil compliance rates on the CRS and VAS were observed, but significant changes were observed in some cognitive tests from baseline to the end of the study. Conclusions Caregiver education had no significant effect on treatment discontinuation, but this may have been due to the low severity of cognitive impairment among the included population at baseline. In addition, the low discontinuation rates meant that no significant difference in treatment compliance was observed.
참고문헌 (30)
- "The world health report 2002:reducing risks, promoting healthy life" (2002)[URL]
- Zhang ZX, "Dementia subtypes in China : prevalence in Beijing, Xian, Shanghai, and Chengdu", Arch Neurol, 62, pp.447~453 (2005)
- Llibre Rodriguez JJ, "Prevalence of dementia in Latin America, India, and China : a population-based cross-sectional survey", Lancet, 372, pp.464~474 (2008)
- Russ TC, "Geographical variation in dementia : systematic review with meta-analysis", Int J Epidemiol, 41, pp.1012~1032 (2012)
- Seltzer B, "Donepezil : a review", Expert Opin Drug Metab Toxicol, 1, pp.527~536 (2005)
- Cacabelos R, "Donepezil in Alzheimer’s disease: from conventional trials to pharmacogenetics", Neuropsychiatr Dis Treat, 3, pp.303~333 (2007)
- Birks JS, "Donepezil for dementia due to Alzheimer’s disease", Cochrane Database Syst Rev, (6), pp.CD001190~ (2018)
- Malouf R, "Donepezil for vascular cognitive impairment", Cochrane Database Syst Rev, (1), pp.CD004395~ (2004)
- Umegaki H, "Discontinuation of donepezil for the treatment of Alzheimer’s disease in geriatric practice", Int Psychogeriatr, 20, pp.800~806 (2008)
- Simpson SH, "A meta-analysis of the association between adherence to drug therapy and mortality", BMJ, 333, pp.15~ (2006)
- "Adherence to long-term therapies: evidence for action" (2003)[URL]
- Hughes CM, "Medication non-adherence in the elderly : how big is the problem?", Drugs Aging, 21, pp.793~811 (2004)
- Elliott RA, "Ability of older people with dementia or cognitive impairment to manage medicine regimens : a narrative review", Curr Clin Pharmacol, 10, pp.213~221 (2015)
- Arlt S, "Adherence to medication in patients with dementia : predictors and strategies for improvement", Drugs Aging, 25, pp.1033~1047 (2008)
- Vermeire E, "Patient adherence to treatment : three decades of research. A comprehensive review", J Clin Pharm Ther, 26, pp.331~342 (2001)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease : report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
- "Highlights of prescribing information: ARICEPT(R) (donepezil hydrochloride)" (2018)[URL]
- 이동영, "Mini-Mental State Examination의 한국 노인 정상규준 연구", 신경정신의학, 41(3), pp.508~525 (2002), 대한신경정신의학회
- Morris JC, "Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type", Int Psychogeriatr, 9(Suppl 1), pp.173~176 (1997)
- Haynes RB, "Interventions to enhance medication adherence", Cochrane Database Syst Rev, (4), pp.CD000011~ (2005)
- Seo YH, "Factors influencing medication adherence in hemodialysis patients : focusing on primary and secondary medical care", Perspect Nurs Sci, 12, pp.60~70 (2015)
- 허재헌, "복약지도 만족도가 복약순응도에 미치는 영향 : 외래환자를 대상으로", 한국임상약학회지, 19(2), pp.110~119 (2009), 한국임상약학회
- Kwon JS, "Medication compliance in psychiatric outpatients of a university hospital", J Korean Neuropsychiatr Assoc, 36, pp.523~529 (1997)
- Taipale H, "Antidementia drug use among community-dwelling individuals with Alzheimer’s disease in Finland : a nationwide register-based study", Int Clin Psychopharmacol, 29, pp.216~223 (2014)
- Shruthi R, "A study of medication compliance in geriatric patients with chronic illnesses at a tertiary care hospital", J Clin Diagn Res, 10, pp.FC40~FC43 (2016)
- Rolnick SJ, "Patient characteristics associated with medication adherence", Clin Med Res, 11, pp.54~65 (2013)
- Jin H, "Factors affecting medication adherence in elderly people", Patient Prefer Adherence, 10, pp.2117~2125 (2016)
- Kulkarni SP, "Long-term adherence with cardiovascular drug regimens", Am Heart J, 151, pp.185~191 (2006)
- Wang W, "Medication adherence and its associated factors among Chinese community-dwelling older adults with hypertension", Heart Lung, 43, pp.278~283 (2014)
- Gast A, "Medication adherence influencing factors—an(updated)overview of systematic reviews", Syst Rev, 8, pp.112~ (2019)